| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/07/2007 | US20070129381 Pharmaceutically active pyrrolidine ester derivatives |
| 06/07/2007 | US20070129380 2-Substituted pyrimidines |
| 06/07/2007 | US20070129379 Hiv integrase inhibitors |
| 06/07/2007 | US20070129378 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | US20070129377 Process for Preparing Substituted Aryl Cycloalkanol Derivatives |
| 06/07/2007 | US20070129376 Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes |
| 06/07/2007 | US20070129375 6-Substituted 2-quinolinones and 2-quinoxalinones as poly (adp-ribose) polymerase inhibitors |
| 06/07/2007 | US20070129374 1,2-dihydro-2-(4-trifluoromethylphenyl)-6-(3-trifluoromethyl-2-pyridinyl)-3H-indazol-3-one; capsaicin receptor ; analgesic, antiinflammatory, hypotensive agent; rheumatoid arthritis, osteoarthritis, headache, migraine, cancer and central nervous system pain, irritable bowel syndrome |
| 06/07/2007 | US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 06/07/2007 | US20070129372 2-substituted-5-phenyl pyrido[1,2-b]pyridizin-6-ones; antiinflammatory agents for conditions related to arthritis, eczema, psoriasis, sunburns, conjunctivitis, pyresis, and pain |
| 06/07/2007 | US20070129371 Novel ethylenediamine derivatives |
| 06/07/2007 | US20070129370 Novel pharmaceutical compositions with increased activity |
| 06/07/2007 | US20070129369 Heteroaryl substituted cyclohexyl-1,4-diamine compounds |
| 06/07/2007 | US20070129368 Tricyclic hydroxamate and benzamide derivatives, compositions and methods |
| 06/07/2007 | US20070129367 Pyridine derivatives as cb2 receptor modulators |
| 06/07/2007 | US20070129366 Methods for the treatment of chronic pain and compositions therefor |
| 06/07/2007 | US20070129365 6-Substituted pyridoindolone derivatives, production and therapeutic use thereof |
| 06/07/2007 | US20070129364 Pyrrolopyridine kinase inhibiting compounds |
| 06/07/2007 | US20070129363 N-type calcium channel antagonists for the treatment of pain |
| 06/07/2007 | US20070129362 N2-Chlorocarbonyl-N4-(2,2-dimethyl-3-oxo-4H-5-pyrido[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine; kinase inhibitors; breast cancer; inhibiting signal transduction cascades in which Syk plays a role |
| 06/07/2007 | US20070129361 LACTAM-CONTAINING DIAMINOALKYL, Beta-AMINOACIDS, Alpha-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS |
| 06/07/2007 | US20070129360 N2-Chlorocarbonyl-N4-(2,2-dimethyl-3-oxo-4H-5-pyrido[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine; kinase inhibitors; breast cancer; inhibiting signal transduction cascades in which Syk plays a role |
| 06/07/2007 | US20070129359 Tetrahydronaphthalene derivatives, processes for their preparation and their use as antiinflammatory agents |
| 06/07/2007 | US20070129358 Sbstituted chroman derivatives, processes for their preparation and their use as antiinflammatory agents |
| 06/07/2007 | US20070129357 Novel crystals of fluorobenzamide derivative |
| 06/07/2007 | US20070129356 Mitotic kinesin inhibitors |
| 06/07/2007 | US20070129355 G-protein-coupled chemoattractant receptor, expressed on T helper cells antagonists such as [4-(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)-5-pyrimidinyl]acetic acid;, used for the treatment of allergic diseases, inflammatory diseases, eosinophil- and basophil-related diseases |
| 06/07/2007 | US20070129354 Biphenyl carboxylic amide p38 kinase inhibitors |
| 06/07/2007 | US20070129353 Alpha-helix mimetics and method relating to the treatment of cancer stem cells |
| 06/07/2007 | US20070129352 Novel crystal forms, methods for their preparation and method for preparation of olanzapine |
| 06/07/2007 | US20070129351 Novel processes for the preparation of cyclopropyl-amide derivatives |
| 06/07/2007 | US20070129350 Methods for treatment of diabetes |
| 06/07/2007 | US20070129349 Alpha, beta -peptide inhibitors; Alzheimer's disease; 2-(4-Chloro-benzenesulfonylamino)-3-phenyl-propionic acid methyl ester |
| 06/07/2007 | US20070129348 Receptor antagonist |
| 06/07/2007 | US20070129347 Cyclohexylacetic acid compounds |
| 06/07/2007 | US20070129346 Melanocortin receptor agonists |
| 06/07/2007 | US20070129345 Lactam compounds and methods of using the same |
| 06/07/2007 | US20070129344 Bicyclic 6-alkylidene-penem beta-lactamase inhibitors and beta-lactam antibiotic combination: a broad spectrum antibiotic |
| 06/07/2007 | US20070129343 New anionic and neutral complexes of ruthenium (II) with nitrogen oxide |
| 06/07/2007 | US20070129342 Compositions Containing Ansamycin |
| 06/07/2007 | US20070129341 Imidazole derivatives used as tafia inhibitors |
| 06/07/2007 | US20070129340 Ed-71 preparation |
| 06/07/2007 | US20070129339 Method of improving beta-adrenergic receptor function |
| 06/07/2007 | US20070129338 Hydroxy-1-azobenzene derivative for treatment of thrombocytopenia |
| 06/07/2007 | US20070129337 Use Of Ketol-Acid Reductoisomerase Inhibitors To Prevent Or Treat Fungal Infection Of Plants |
| 06/07/2007 | US20070129336 Camphanylidene and phenylalkyl inositol polyphosphate compounds, compositions, and methods of their use |
| 06/07/2007 | US20070129335 T-type calcium channel blocker |
| 06/07/2007 | US20070129334 Orally Active Purine-Based Inhibitors of Heat Shock Protein 90 |
| 06/07/2007 | US20070129333 1-Thia-2,4a-diaza-cyclopenta[b]naphthalene-3,4-diones and related compounds as anti-infective agents |
| 06/07/2007 | US20070129332 Processes to prepare eplerenone |
| 06/07/2007 | US20070129331 Pharmaceutical compositions and methods of use of lipophilic, silicon-substituted, cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs and derivatives |
| 06/07/2007 | US20070129330 1,3-Diaza-dibenzo[e,h]azulenes for the treatment of central nervous system diseases and disorders |
| 06/07/2007 | US20070129329 Stabilized pharmaceutical composition of pramipexole and method of preparation thereof |
| 06/07/2007 | US20070129328 Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration |
| 06/07/2007 | US20070129327 2-[(2-{(1R,2R)-2-[(1E)-4-hydroxy-4-methyl-1-nonenyl]-5-oxocyclopentyl}ethyl)sulfanyl]-1,3-thiazole-4-carboxylic acid; isomers; increase blood flow for improving symptoms such as lumbago, lower limb pain, lower limb numbness, intermittent claudication, bladder and rectal disorder or sexual dysfunction |
| 06/07/2007 | US20070129326 Methods for producing modified microcrystalline chitosan and uses therefor |
| 06/07/2007 | US20070129325 Use of corrinoids for application in skin diseases |
| 06/07/2007 | US20070129321 Arrays of site-isolated biological entities; use of direct-write nanolithographic printing; enables a wide variety of studies involving viruses that are not possible with microarrays |
| 06/07/2007 | US20070129318 Antisense oligonucleotide having anticancerous activity |
| 06/07/2007 | US20070129317 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity |
| 06/07/2007 | US20070129316 antidepressant comprising at least one of scymnol or scymnol esters, soybean isoflavones and soybean isoflavone glycosides, curcumin, and or cholic acid; herbal medicine |
| 06/07/2007 | US20070129315 3-O- beta -D-xylopyranosyl-3-O-demethylthiocolchicine or 3-O- beta -L-xylopyranosyl-3-O-demethylthiocolchicine; gout , antiinflammation; muscle relaxant |
| 06/07/2007 | US20070129314 Treating Type II diabetes comprising coadministering metformin and an inhibitor of dipeptidylpeptidase IV, especially a peptidomimetic containing a pyrrolidine ring in an amount insufficient to suppress the immune system |
| 06/07/2007 | US20070129312 Convalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites |
| 06/07/2007 | US20070129310 Antibacterial agents |
| 06/07/2007 | US20070129299 Compositions and methods for enhanced mucosal delivery of pyy peptide |
| 06/07/2007 | US20070129297 Treatment and prevention of asthma |
| 06/07/2007 | US20070129292 Treatment of aspergillus infections with alpha thymosin peptides |
| 06/07/2007 | US20070129286 Treatment Solution and Method for Preventing Posterior Capsular Opacification by Selectively Inducing Detachment And/Or Death of Lens Epithelial Cells |
| 06/07/2007 | US20070129283 Compositions and methods for reducing food cravings |
| 06/07/2007 | US20070129282 Pharmaceutical treatments and compositions |
| 06/07/2007 | US20070128703 An immobilized acceptor having at least two sugar units is contacted with Pasteurella multocida transferases selected from pmHAS, pmCS, pmHS, PglA, in a reaction medium with a sugar precursor selected from uridine diphosphate (UDP)-glucosamine, UDP-N-acetylglucosamine, or UDP-N-acetylgalactosamine |
| 06/07/2007 | US20070128695 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 06/07/2007 | US20070128667 Secreted neural apoptosis inhibiting proteins |
| 06/07/2007 | US20070128591 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 06/07/2007 | US20070128327 Package drink |
| 06/07/2007 | US20070128310 Astaxanthin-containing pet foods |
| 06/07/2007 | US20070128299 Functional beverage and composition |
| 06/07/2007 | US20070128298 Compositions and methods for increasing insulin sensitivity |
| 06/07/2007 | US20070128296 Reduction of reactive oxygen species in chronic wound management |
| 06/07/2007 | US20070128294 Treatment and prevention of liver adverse conditions using gallium |
| 06/07/2007 | US20070128292 rich in polyunsaturated fatty acids such as linolenic acid, eicosapentaenoic acid, docosahexaenoic acid and antioxidant; cardiovascular diseases |
| 06/07/2007 | US20070128290 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 06/07/2007 | US20070128289 Nano-and/or micro-particulate formulations for local injection-based treatment of vascular diseases |
| 06/07/2007 | US20070128288 Artificial tears or vehicles for ophthalmic drugs; viscosity; hydroxypropyl methylcellulose and a combination of two other polymers: guar gum, a carboxyvinyl polymer (polymer of acrylic acid crosslinked with allyl sucrose or allylpentaerythritol), hydroxyethyl cellulose or dextran, dry eye |
| 06/07/2007 | US20070128287 Dermal composition for external use |
| 06/07/2007 | US20070128285 Pharmaceutical composition for oral administration |
| 06/07/2007 | US20070128284 Using sulfur-containing antioxidant, such as N-acetylcysteine in delivery vehicle including polyoxyethylene-polyoxypropylene block copolymers for therapy of dry mouth and/or thickened saliva resulting from altered, reduced or absent saliva flow |
| 06/07/2007 | US20070128283 Oral osmotic drug delivery system |
| 06/07/2007 | US20070128282 Oral osmotic drug delivery system |
| 06/07/2007 | US20070128281 Oral osmotic drug delivery system |
| 06/07/2007 | US20070128280 Oral osmotic drug delivery system |
| 06/07/2007 | US20070128279 Extended Release Dosage Form |
| 06/07/2007 | US20070128278 Pharmaceutical formulations |
| 06/07/2007 | US20070128277 Coated tablets |
| 06/07/2007 | US20070128276 Controlled release compositions comprising nimesulide |
| 06/07/2007 | US20070128275 Trazodone composition for once a day administration |
| 06/07/2007 | US20070128273 Composition containing medicine extremely slightly soluble in water and method for preparation thereof |
| 06/07/2007 | US20070128271 Formulation and manufacturing process for calcium acetate capsules |
| 06/07/2007 | US20070128270 Pharmaceutical formulations containing 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-n-methyl-1-benzofuran-3-carboxamide and method of making the same |